)
Business philosophy12 Aug 2025
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
Eli Lilly and Company
Eli Lilly and Company (LLY) investor relations material
Eli Lilly and Company AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary4 May, 2026
Opening remarks and agenda
The meeting was held virtually to ensure broad shareholder participation and followed a set agenda as outlined in the notice and slide presentation.
Shareholders were reminded of meeting conduct rules and the process for submitting questions.
The meeting was called to order with a quorum present, allowing official business to proceed.
Board and executive committee updates
Four directors were nominated for election to serve until 2029, with their qualifications detailed in the proxy statement.
The board recommended voting for all director nominees and management proposals.
Shareholder proposals
Proposal 6 called for an independent board chair, citing legal and governance risks, insider ownership, and industry trends.
Proposal 7 requested annual disclosure of lobbying expenditures, including indirect and dark money payments, to improve transparency.
The board recommended voting against both shareholder proposals.
Explain failure of board-backed proposals 4 and 5
Foundayo advantages over other oral GLP-1s
Impact of $55B manufacturing spend on supply
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Eli Lilly and Company
- Q1 2026 revenue up 56% to $19.8B, EPS up 156%, with raised guidance and major product milestones.LLY
Q1 20261 May 2026 - Key votes include director elections, governance reforms, and executive pay approval.LLYProxy filing20 Mar 2026
- Record results, governance reforms, and strong board oversight define this year's proxy.LLYProxy filing20 Mar 2026
- Record 2025 results, major governance reforms, and expanded access initiatives drive shareholder focus.LLYProxy Filing6 Mar 2026
- Orforglipron nears U.S. launch as portfolio and global expansion drive future growth.LLYTD Cowen 46th Annual Health Care Conference2 Mar 2026
- Q4 2025 revenue rose 43% to $19.3B; 2026 guidance set at $80–$83B revenue.LLYQ4 20254 Feb 2026
- Q2 revenue up 36% with raised guidance, strong incretin sales, and major pipeline progress.LLYQ2 20242 Feb 2026
- Manufacturing expansion, pipeline progress, and broadening access drive near-term growth.LLYGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- Oncology pipeline and revenue surge with new modalities, pivotal trials, and strong brand growth.LLYStatus Update31 Jan 2026
Next Eli Lilly and Company earnings date
Q2 20265 Aug, 2026
Eli Lilly and Company
Next Eli Lilly and Company earnings date
Q2 20265 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge8 Aug 2025
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces.
)
Business philosophy3 Jul 2025
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
Frequently asked questions
Explore our global coverage